Lancet[journal] 检索结果

2121. Bimekizumab: dual inhibition as a promising tool in the management of hidradenitis suppurativa.

作者: Elisa Molinelli.;Oriana Simonetti.
来源: Lancet. 2024年403卷10443期2457-2459页

2122. A right atrial mass and colonic cancer in a patient with Lynch syndrome.

作者: Stéphane Ederhy.;Pierre Demondion.;Amal Ali.;Françoise Montravers.;Baptiste Cervantes.;Pierre Fouret.;Ariel Cohen.;Thierry Andre.
来源: Lancet. 2024年403卷10441期e32页

2123. Department of Error.

来源: Lancet. 2024年403卷10441期2292页

2124. Department of Error.

来源: Lancet. 2024年403卷10441期2292页

2125. Department of Error.

来源: Lancet. 2024年403卷10441期2292页

2126. Integrated HIV, diabetes, and hypertension care in sub-Saharan Africa - Authors' reply.

作者: Shabbar Jaffar.
来源: Lancet. 2024年403卷10441期2292页

2127. Integrated HIV, diabetes, and hypertension care in sub-Saharan Africa.

作者: Songtao Cai.;Zhijie Xu.;Yang Zhao.;Liesl Zühlke.
来源: Lancet. 2024年403卷10441期2291页

2128. Integrated HIV, diabetes, and hypertension care in sub-Saharan Africa.

作者: Diane Havlir.;Moses R Kamya.;Maya Petersen.
来源: Lancet. 2024年403卷10441期2291-2292页

2129. Purpura fulminans in young women with influenza and co-infections.

作者: Matthew Brown.;John Gerrard.;Catherine McDougall.;Julie MacPhail.;Olivia Williams.
来源: Lancet. 2024年403卷10441期2290-2291页

2130. Antimicrobial resistance and people living with disabilities.

作者: Yusuff Adebayo Adebisi.
来源: Lancet. 2024年403卷10441期2289页

2131. Expedited approvals and adverse drug reactions in women.

作者: Constance Viehbeck.
来源: Lancet. 2024年403卷10441期2289-2290页

2132. Why not eliminate HTLV-1 while eliminating HIV-1?

作者: Goedele N Maertens.;Damian F J Purcell.;Carolina Rosadas.;Daniel Bradshaw.;Mirna Biglione.;Graham P Taylor.;Fabiola Martin.
来源: Lancet. 2024年403卷10441期2288-2289页

2133. The Beni-Koji scandal and Japan's unique health food system.

作者: Takanao Hashimoto.;Akihiko Ozaki.;Hayase Hakariya.;Kenzo Takahashi.;Tetsuya Tanimoto.
来源: Lancet. 2024年403卷10441期2287-2288页

2134. Caesarean section: the history of a controversial operation.

作者: Sally Frampton.
来源: Lancet. 2024年403卷10441期2282-2283页

2135. Gene therapy proves successful in treating hereditary deafness.

作者: Ellen Reisinger.;Ivana Trapani.
来源: Lancet. 2024年403卷10441期2267-2269页

2136. Expanded Programme on Immunization at 50 years: its legacy and future.

作者: Brian Wahl.;Virginia E Pitzer.
来源: Lancet. 2024年403卷10441期2265-2267页

2137. Cyberattacks on health care-a growing threat.

作者: The Lancet.
来源: Lancet. 2024年403卷10441期2263页

2138. LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial.

作者: Andreas Baumbach.;Niels van Royen.;Ignacio J Amat-Santos.;Martin Hudec.;Matjaz Bunc.;Alexander Ijsselmuiden.;Peep Laanmets.;Daniel Unic.;Bela Merkely.;Renicus S Hermanides.;Vlasis Ninios.;Marcin Protasiewicz.;Benno J W M Rensing.;Pedro L Martin.;Fausto Feres.;Manuel De Sousa Almeida.;Eric van Belle.;Axel Linke.;Alfonso Ielasi.;Matteo Montorfano.;Mark Webster.;Konstantinos Toutouzas.;Emmanuel Teiger.;Francesco Bedogni.;Michiel Voskuil.;Manuel Pan.;Oskar Angerås.;Won-Keun Kim.;Jürgen Rothe.;Ivica Kristić.;Vicente Peral.;Scot Garg.;Hesham Elzomor.;Akihiro Tobe.;Marie-Claude Morice.;Yoshinobu Onuma.;Osama Soliman.;Patrick W Serruys.; .
来源: Lancet. 2024年403卷10445期2695-2708页

Transcatheter aortic valve implantation is an established, guideline-endorsed treatment for severe aortic stenosis. Precise sizing of the balloon-expandable Myval transcatheter heart valve (THV) series with the aortic annulus is facilitated by increasing its diameter in 1·5 mm increments, compared with the usual 3 mm increments in valve size. The LANDMARK trial aimed to show non-inferiority of the Myval THV series compared with the contemporary THVs Sapien Series (Edwards Lifesciences, Irvine, CA, USA) or Evolut Series (Medtronic, Minneapolis, MN, USA).

2139. New-generation Myval transcatheter heart valve in severe aortic stenosis.

作者: Mariama Akodad.;Emmanuel Gall.
来源: Lancet. 2024年403卷10445期2664-2665页

2140. Poetry for rewilding the medical and health humanities.

作者: Luz Mar González-Arias.;Kelley Swain.
来源: Lancet. 2024年404卷10452期516-517页

结果排序

文献格式

出版时间

出版类型

出版语言

2121. Bimekizumab: dual inhibition as a promising tool in the management of hidradenitis suppurativa.

2122. A right atrial mass and colonic cancer in a patient with Lynch syndrome.

2123. Department of Error.

2124. Department of Error.

2125. Department of Error.

2126. Integrated HIV, diabetes, and hypertension care in sub-Saharan Africa - Authors' reply.

2127. Integrated HIV, diabetes, and hypertension care in sub-Saharan Africa.

2128. Integrated HIV, diabetes, and hypertension care in sub-Saharan Africa.

2129. Purpura fulminans in young women with influenza and co-infections.

2130. Antimicrobial resistance and people living with disabilities.

2131. Expedited approvals and adverse drug reactions in women.

2132. Why not eliminate HTLV-1 while eliminating HIV-1?

2133. The Beni-Koji scandal and Japan's unique health food system.

2134. Caesarean section: the history of a controversial operation.

2135. Gene therapy proves successful in treating hereditary deafness.

2136. Expanded Programme on Immunization at 50 years: its legacy and future.

2137. Cyberattacks on health care-a growing threat.

2138. LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial.

2139. New-generation Myval transcatheter heart valve in severe aortic stenosis.

2140. Poetry for rewilding the medical and health humanities.